genoptic gentamicin 3mg/ml (as sulfate) eye drops
abbvie pty ltd - gentamicin sulfate, quantity: 3 mg/ml (equivalent: gentamicin, qty 3 mg/ml) - eye drops, solution - excipient ingredients: polyvinyl alcohol; dibasic sodium phosphate heptahydrate; sodium chloride; disodium edetate; benzalkonium chloride; sodium hydroxide; purified water; hydrochloric acid - gentopic eye drops are indicated in the topical treatment of infections of the external eye and its adnexa caused by susceptible bacteria. such infections include conjunctivitis, keratitis, keratoconjunctivitis, corneal ulcers, blepharitis, blepharoconjunctivits, acute meibomianitis and dacryocystitis.
atropt 1% atropine sulfate monohydrate 10mg/ml eye drops bottle
aspen pharma pty ltd - atropine sulfate monohydrate, quantity: 9.9737 mg/ml - eye drops, solution - excipient ingredients: boric acid; disodium edetate; benzalkonium chloride; hypromellose; water for injections - indications as at 06 august 1999: atropt eye drops are indicated where it is necessary to dilate the pupil and paralyse accomodation.
eye-biz big eyes 2 enhanced disposable contact lens
eye-biz pte. ltd. - ophthalmology - this daily wear color contact lens is designed for the correction of refractive ametropia (myopia) in aphakic or non-aphakic persons with non-disease eyes.
eye drops 9612- eye drops liquid
professional complementary health formulas - eye (ciliary, humor, lens) 12x - for the temporary relief of watery, itchy, red, or burning eye(s).* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.
xiidra lifitegrast 50 mg/ml eye drops single-use ampoules
bausch & lomb australia pty ltd - lifitegrast, quantity: 50 mg/ml - eye drops, solution - excipient ingredients: sodium chloride; sodium hydroxide; sodium thiosulfate pentahydrate; water for injections; dibasic sodium phosphate - xiidra is indicated for the treatment of moderate to severe dry eye disease in adults for whom prior use of artificial tears has not been sufficient.
cequa ciclosporin 900 microgram/ml eye drops ampoule
sun pharma anz pty ltd - ciclosporin, quantity: 900 microgram/ml - eye drops - excipient ingredients: peg-40 hydrogenated castor oil; octoxinol 40; monobasic sodium phosphate dihydrate; dibasic sodium phosphate; sodium chloride; povidone; water for injections; hydrochloric acid; sodium hydroxide - cequa is indicated to increase tear production in patients with moderate to severe keratoconjunctivitis sicca (dry eye) where prior use of artificial tears has not been sufficient.
ikervis ciclosporin 1 mg/ml eye drops emulsion ampoule
seqirus pty ltd - ciclosporin, quantity: 1 mg/ml - eye drops, emulsion - excipient ingredients: medium chain triglycerides; cetalkonium chloride; glycerol; tyloxapol; poloxamer; sodium hydroxide; water for injections - treatment of severe keratitis in adult patients with dry eye disease which has not improved despite treatment with tear substitutes.
eikance 0.01% atropine sulfate monohydrate 100 microgram/1 ml eye drops solution packed in single-dose ampoules
aspen pharmacare australia pty ltd - atropine sulfate monohydrate, quantity: 0.1027 mg/ml (equivalent: atropine sulfate, qty 0.1 mg/ml) - eye drops, solution - excipient ingredients: citric acid monohydrate; sodium chloride; hydrochloric acid; water for injections; sodium hydroxide - eikance 0.01% is indicated as a treatment to slow the progression of myopia in children aged from 4 to 14 years. atropine treatment may be initiated in children when myopia progresses greater than or equal to -1.0 d per year.
alphagan 0.2% w/v (2 mg/ml) eye drops, solution
pco manufacturing ltd. - brimonidine tartrate - eye drops, solution - 0.2 percent weight/volume - brimonidine - sympathomimetics in glaucoma therapy - reduction of elevated intraocular pressure (iop) in patients with open angle glaucoma or ocular hypertension
xalatan 50 micrograms/ml eye drops, solution
ltt pharma limited - latanoprost - eye drops, solution - 50 microgram(s)/millilitre - prostaglandin analogues1); latanoprost - reduction of elevated intraocular pressure in patients with open angle glaucoma and ocular hypertension. reduction of elevated intraocular pressure in paediatric patients with elevated intraocular pressure and paediatric glaucoma